Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...
A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.
In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...
2d
Hosted on MSNMedical Report: Are asthma inhalers bad for the environment?Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...
There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...
With a bewildering number of new drugs available for asthma and COPD, HCPs are increasingly making their decisions based on the cost and the inhaler device. They need to consider which inhaler ...
SSM Health Waupun Memorial Hospital, 620 W. Brown St., will introduce a new outpatient pulmonary rehabilitation program ...
The new chief medical officer of the Pulmonary Fibrosis Foundation speaks about patients in rural areas, research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results